Citadel Advisors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.71M | Sell |
|
|||||
|
2025
Q1 | $11M | Sell |
|
|||||
|
2024
Q4 | $17.9M | Sell |
|
|||||
|
2024
Q3 | $28.8M | Buy |
|
|||||
|
2024
Q2 | $11.9M | Buy |
|
|||||
|
2024
Q1 | $3.59M | Sell |
|
|||||
|
2023
Q4 | $5.01M | Buy |
|
|||||
|
2023
Q3 | $163K | Sell |
|
|||||
|
2023
Q2 | $3.08M | Sell |
|
|||||
|
2023
Q1 | $48.1M | Buy |
|
|||||
|
2022
Q4 | $33.9M | Sell |
|
|||||
|
2022
Q3 | $42.2M | Buy |
|
|||||
|
2022
Q2 | $28.1M | Sell |
|
|||||
|
2022
Q1 | $38.7M | Buy |
|
|||||
|
2021
Q4 | $41.3M | Buy |
|
|||||
|
2021
Q3 | $42.3M | Buy |
|
|||||
|
2021
Q2 | $12.4M | Sell |
|
|||||
|
2021
Q1 | $20.1M | Sell |
|
|||||
|
2020
Q4 | $24.5M | Buy |
|
|||||
|
2020
Q3 | $373K | Sell |
|
|||||
|
2020
Q2 | $774K | Buy |
|
|||||
|
2020
Q1 | $41K | Buy |
|
|||||
|
2019
Q4 | $35K | Buy |
|
|||||
|
2019
Q3 | – | Hold |
|
|||||
|
2019
Q2 | – | Hold |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $9K | Sell |
|
|||||
|
2018
Q3 | $59K | Sell |
|
|||||
|
2018
Q2 | $159K | Sell |
|
|||||
|
2018
Q1 | $2.83M | Buy |
|
|||||
|
2017
Q4 | $2.1M | Sell |
|
|||||
|
2017
Q3 | $4.72M | Buy |
|
|||||
|
2017
Q2 | $2.3M | Buy |
|
|||||
|
2017
Q1 | $417K | Buy |
|
|||||
|
2016
Q4 | $213K | Sell |
|
|||||
|
2016
Q3 | $3.39M | Buy |
|
|||||
|
2016
Q2 | $640K | Buy |
|
|||||
|
2016
Q1 | $439K | Buy |
|
|||||
|
2015
Q4 | $1.67M | Buy |
|
|||||
|
2015
Q3 | $889K | Sell |
|
|||||
|
2015
Q2 | $19.4M | Buy |
|
|||||
|
2015
Q1 | $9.41M | Buy |
|
|||||
|
2014
Q4 | $2.71M | Sell |
|
|||||
|
2014
Q3 | $2.12M | Buy |
|
|||||
|
2014
Q2 | $1.32M | Buy |
|
|||||
|
2014
Q1 | $1.37M | Sell |
|
|||||
|
2013
Q4 | $2.69M | Sell |
|
|||||
|
2013
Q3 | $12.3M | Buy |
|
|||||
|
2013
Q2 | $1.27M | Buy |
|